Kanabo Group (LON:KNB) Stock Price Up 17.6% – Should You Buy?

Kanabo Group Plc (LON:KNBGet Free Report) shot up 17.6% during trading on Wednesday . The company traded as high as GBX 1 ($0.01) and last traded at GBX 1 ($0.01). 934,634 shares traded hands during trading, an increase of 116% from the average session volume of 432,659 shares. The stock had previously closed at GBX 0.85 ($0.01).

Kanabo Group Stock Performance

The stock has a market cap of £6.32 million, a P/E ratio of -80.00 and a beta of 3.04. The company has a debt-to-equity ratio of 3.49, a current ratio of 2.78 and a quick ratio of 24.36. The company has a fifty day moving average of GBX 1.05 and a 200 day moving average of GBX 1.27.

About Kanabo Group

(Get Free Report)

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.

See Also

Receive News & Ratings for Kanabo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kanabo Group and related companies with MarketBeat.com's FREE daily email newsletter.